Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Beijing, China.
Traditional Chinese Medicine (TCM) Biological Genetics (Heilongjiang Province Double First-Class Construction Interdiscipline), Beijing, China.
Biomed Chromatogr. 2024 Nov;38(11):e5989. doi: 10.1002/bmc.5989. Epub 2024 Aug 22.
Epilepsy (EP) is one of the most common neurological diseases in the world. Anemarrhena asphodeloides Bunge. (AA), as a typical heat-cleaning medicine, has been proven to possess the antiepileptic effect in clinical and experimental studies. Anemarrhena asphodeloides steroidal saponins (AAS) are main components. However, the therapeutic effects and underlying mechanisms of AAS against EP are not been fully elucidated. In this study, 63 steroidal saponins were discovered in AAS by UPLC-Q-TOF/MS analysis. Pharmacological and behavioral analysis demonstrated that AAS could significantly lower the Racine classification and reduce the frequency of generalized spike rhythm the rate of tetanic seizures in kainic acid-induced epileptic rats. Hematoxylin and eosin and Nissl staining-indicated AAS could significantly improve hippocampal injury and neuron loss in epileptic rats. TMT proteomic analysis discovered 26 different expressed proteins (DEPs), which were identified as the rescue proteins. After bioinformatic analysis, Heat Shock Protein 90 Alpha Family Class B Member 1 (Hsp90ab1) and Tyrosine 3-Monooxygenase (Ywhab) were screened as key DEPs and verified by western blotting. AAS could significantly inhibited the up-regulation of Hsp90ab1 and Ywhab in EP rats; these two proteins might be the key targets of AAS in treating EP.
癫痫(EP)是世界上最常见的神经系统疾病之一。知母(AA)作为一种典型的清热药,已被临床和实验研究证明具有抗癫痫作用。知母甾体皂苷(AAS)是主要成分。然而,AAS 对 EP 的治疗效果和潜在机制尚未完全阐明。在这项研究中,通过 UPLC-Q-TOF/MS 分析在 AAS 中发现了 63 种甾体皂苷。药理和行为分析表明,AAS 可显著降低海人酸致痫大鼠的 Racine 分级和全面性棘波节律频率,降低强直发作的频率。苏木精-伊红和尼氏染色表明 AAS 可显著改善癫痫大鼠的海马损伤和神经元丢失。TMT 蛋白质组学分析发现了 26 种不同表达的蛋白质(DEPs),这些蛋白质被鉴定为挽救蛋白质。经过生物信息学分析,热休克蛋白 90α 家族 B 成员 1(Hsp90ab1)和酪氨酸 3-单加氧酶(Ywhab)被筛选为关键的 DEPs,并通过 Western blot 验证。AAS 可显著抑制 EP 大鼠中 Hsp90ab1 和 Ywhab 的上调;这两种蛋白质可能是 AAS 治疗 EP 的关键靶点。